Ads
related to: Novavax and Investors- Merrill Advisor Match
With Merrill Advisor Match, We've
Made It Easier To Find An Advisor.
- Preparing For Retirement
What Can You Do Now to Accomplish
Your Retirement Goals Later?
- Our Products & Solutions
Products And Services You Need
To Pursue Your Financial Goals.
- Resources & Insights
Take Advantage Of Tools That
Offer Insight Into Today's Markets.
- Merrill Advisor Match
Search results
Shah Capital calls for board shake-up at Novavax (NASDAQ:NVAX)
Seeking Alpha· 1 week agoShah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and...
Novavax investor Shah Capital pushes for board shakeup
Reuters via AOL· 1 week ago(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been...
Better Buy: Bluebird Bio Vs. Novavax
Motley Fool via Yahoo Finance· 2 weeks agoLastly, a potential acquirer would have much more to gain, namely a team of gene editing experts, by buying out Bluebird Bio over Novavax. One more...
Q3 2024 EPS Estimates for Novavax, Inc. Reduced by Zacks Research (NASDAQ:NVAX)
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Free Report) – Stock analysts at Zacks Research decreased their Q3 2024 EPS estimates for shares of Novavax in a research report ...
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Market Watch· 1 week agoHedge fund Shah Capital on Monday called for an “urgent shake up” at the board of Novavax over...
Shah Capital proposes new directors for Novavax board By Investing.com
Investing.com· 1 week agoThe investment firm, which has been a long-term strategic investor in Novavax, expressed its...
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 2 weeks agoBefore you buy stock in Novavax, consider this: The Motley Fool Stock Advisor analyst team just...
Novavax (NASDAQ:NVAX) Trading 3.5% Higher
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report)’s stock price traded up 3.5% during mid-day trading on Friday . The stock traded as high as $4.48 and last traded at $4.45. 1,149,644 ...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 1 week agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Shah Capital nominates two highly qualified independent director candidates for Novavax - Novavax...
Benzinga· 1 week agoBelieves the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of Novavax, in a letter to
